Conditional RNA interference achieved by Oct-1 POU/rtTA fusion protein activator and a modified TRE-mouse U6 promoter

Biochem Biophys Res Commun. 2007 Mar 23;354(4):906-12. doi: 10.1016/j.bbrc.2007.01.081. Epub 2007 Jan 24.

Abstract

RNA interference (RNAi) is a powerful technique and is widely used to down-regulate expression of specific genes in cultured cells and in vivo. In this paper, we report our development of a new tetracycline-inducible RNAi expression using a modified TRE-mouse U6 promoter in which the distal sequence element (DSE) was replaced by the tetracycline-responsive element (TRE). The modified TRE-mouse U6 promoter can be activated by a Tet-on version tetracycline-regulated artificial activator rTetOct which was constructed by fusing the rtTA DNA binding domain with the Oct-1 POU activation domain. This rTetOct/TRE-U6 system was successfully applied to conditionally and reversibly down-regulate the expression of endogenous p53 gene in MCF7 cells, and the expression of beta-defensin gene (mBin1b) either transiently expressed in COS7 cells or stably expressed in CHO cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / metabolism
  • Animals
  • Breast Neoplasms / metabolism
  • CHO Cells
  • COS Cells
  • Chlorocebus aethiops
  • Cricetinae
  • Cricetulus
  • Doxycycline / pharmacology
  • Humans
  • Mice
  • Octamer Transcription Factor-1 / genetics*
  • Promoter Regions, Genetic
  • RNA Interference* / drug effects
  • RNA, Small Interfering / physiology
  • RNA, Small Nuclear / metabolism*
  • Tetracycline / pharmacology*
  • Tumor Suppressor Protein p53 / biosynthesis
  • beta-Defensins / biosynthesis

Substances

  • Octamer Transcription Factor-1
  • Pou2f1 protein, mouse
  • RNA, Small Interfering
  • RNA, Small Nuclear
  • Spag11 protein, mouse
  • Tumor Suppressor Protein p53
  • U6 small nuclear RNA
  • beta-Defensins
  • Tetracycline
  • Doxycycline